Related by context. All words. (Click for frequent words.) 61 Statements - 60 orally ingestible insulin 59 Cautionary Statements Certain 59 statements describe APDN 58 describe APDN 58 Anviron undertakes 57 involverisks 57 historical facts areforward 57 Safe Harbor Forward Looking 57 Azedra TM Onalta TM 57 includingstatements regarding 56 EnterpriseTenFold SOA 56 involve risksand uncertainties 56 reflect Ronn Motor 56 nothistorical facts 56 DEALERTRACK HOLDINGS INC. 56 andassumptions 56 reflect HRTE 55 Isis Alnylam 55 looking statementsare 55 reflect Ronn Motors 54 aresubject 54 Statements Certain 54 HepeX B TM 54 arebased 54 PRECISE trial 54 myFreightWorld undertakes 54 MKC# 54 CAUTIONARY STATEMENT Statements 54 Theforward looking 54 www.medicago.com 54 Somatuline R Depot 54 currentexpectations 54 withinthe meaning 53 TomoTherapy judgments 53 molecular chaperone regulation 53 LEVADEX ™ 53 Suchforward looking 53 Agria beliefs 53 Forward Looking StatementsThis press 53 PLAYLOGIC 53 within themeaning 53 CAUTIONARY STATEMENT Estimates 53 Thesestatements 53 describe CoBiz 53 MultiCell bases 53 reflect DTRO 53 OR INFORMATION INVOLVE 53 Ceragenin ™ 53 concerning Numerex 53 Statement Statements 53 Zemiva TM Trofex TM 52 SAFE HARBOUR 52 thedate hereof 52 GigaMedia cautions readers 52 Pixelplus cautions readers 52 Anthracite assumes 52 Azedra ™ 52 guarantees offuture performance 52 proprietary intranasal insulin 52 areforward looking 52 Theseforward looking 52 BEMA TM Fentanyl 52 Looking Statements -Dunshaughlin Co Meath 51 trivalent seasonal influenza 51 please visit www.advaxis.com 51 HDL Selective Delipidation 51 thisrelease 51 CLX Investments 51 concerning VAALCO 51 looking statementsâ € 51 Assumptions underlying 51 forward lookinginformation 51 statements arebased 51 Statements Statements 51 PLAYLOGIC assumes 51 hypoxia activated prodrug 51 Geac intentions 51 Sinovac beliefs 51 dermaceutical 51 meaningof 51 reflect SpatiaLight 51 those CombinatoRx contemplated 51 sapacitabine CYC# 51 suchforward looking 51 LE DT 51 subsidiaries visit http:/www.apricusbio.com 51 please visit http:/www.sunesis.com 51 reflect Sentry Select 51 theseforward looking 51 newproducts 50 cadence regulatory approvals 50 RXi Pharmaceutical Corporation 50 muscarinic receptor agonist 50 â € œwill â 50 http:/www.bphx.com 50 terms Measured Indicated 50 reflect Intelsat intentions 50 FermaVir 50 regardingthe 50 www.bphx.com 50 expressly qualifies 50 please visit www.sucampo.com 50 phenylalanine ammonia lyase 50 DISCLOSURE NOTICE 50 XFMedia beliefs 50 ALDA assumes 50 IMiDs R 50 UPLYSO 50 thispress release 50 AIMM trial 50 evaluating satraplatin 50 Cautionary Statements section 50 Gilead assumes 50 BY MAKING THESE 50 novel oral anticoagulant 50 DE BEIRA 50 Silence Therapeutics assumes 50 ALL STATEMENTS CONTAINED 50 AERx ® 50 initiate Phase Ib 50 underlying sulfide mineralization 50 ESPRE Solutions Inc. 50 futureresults 50 visit http:/www.parpharm.com/ 50 contained inthis 50 forwarda ^ looking 50 GenVec cautions 50 small molecule chemotherapeutic 50 Sirtris Pharmaceuticals contemplated 50 please visit www.middlebrookpharma.com 50 subjectto 50 OR SIMILAR STATEMENTS ARE 49 XSEL beliefs 49 involve risks anduncertainties 49 STATEMENTS Certain 49 http:/www.camtek.co.il 49 Canvaxin TM 49 OTCS undertakes 49 concerning Alnylam 49 SciClone assumes 49 Pharmion undertakes 49 entitled Caution Regarding 49 www.innovaro.com 49 Nevoro considers 49 initiate Phase IIb 49 GBOE 49 HEPLISAV ™ 49 Scivanta 49 those Zalicus contemplated 49 Numerex cautions 49 looking statements.Such 49 dispositions joint ventures 49 HEPLISAV TM hepatitis B 49 www.sorin.com 49 forwardlooking 49 ADSI cautions 49 investigating pralatrexate 49 constituteforward looking 49 reflecting Maximizer Software 49 generation URAT1 inhibitor 49 aEURoeforward looking 49 EndoBarrier ™ 49 Assumptions relating 49 iCo Therapeutics 49 BigString Corporation intends 49 Inc SPPI 49 treat hyperproliferative disorders 49 LE SN# 49 visit www.parpharm.com 49 topical agent Xantryl 49 SAFE HARBOR Statement 49 anyforward looking 49 http:/www.lecroy.com 48 tramiprosate Alzhemed TM 48 statementsregarding 48 Cerashield TM 48 SAFE HARBOR Except 48 Phase III LibiGel 48 www.accentia.net 48 Phase #/#a trial 48 EXPECTED RESULTS MAY INCLUDE 48 Vaxfectin R adjuvant 48 Puricase PEG uricase 48 OSRS 48 RH1 targeted chemotherapeutic agent 48 www.idgenterprise.com 48 reflect iSIGN Media 48 Capstone cautions 48 Licenses Novel 48 Bellwether undertakes 48 information visit www.parpharm.com 48 Agenus 48 preclinical studies Vion 48 reflect PREIT 48 BioSante LibiGel Phase III 48 BiTE R 48 please visit http:/www.toshiba.com/taec/ 48 NASDAQ CVV 48 myasthenia gravis Huntington 48 APNB 48 NovaBay disclaims any 48 LOOKING INFORMATION Except 48 HuCAL antibodies 48 www.themedicinescompany.com 48 verbatim extract 48 serious systemic Staphylococcal 48 ZIOPHARM Oncology 48 statementscontained 48 MicuRx 48 theforward looking 48 couldcause actual results 48 Phase Ib IIa 48 PROTECT AF 48 CompanyaEUR TM s 48 negations thereof generally 48 Cautionary Statements Statements 48 reflect Medicago 48 www.allos.com 48 Statement Certain 48 reflect GuestLogix 48 CAUTIONARY NOTE 48 PerClot 48 Pharsight WinNonlin 48 concerning Xanthus 48 beidentified 48 Acetavance TM intravenous acetaminophen 48 including withoutlimitation 48 Resverlogix Corp. 48 www.chembio.com 48 Although Franconia Minerals 48 withrespect 48 risksand uncertainties 48 historicalfacts 48 Platina Energy believes 48 EndoTAG TM 48 product TNFerade TM 47 mergers dispositions 47 ionotropic glutamate receptor antagonists 47 TEWI officials 47 Laurion cautions against 47 TechFaith beliefs 47 regarding ERF Wireless 47 OTCBB VCTPF 47 Files Shelf Registration 47 La Planada Gold 47 www.amyris.com 47 MTI Micro disclaim 47 contain Senomyx flavor 47 http:/www.cytogen.com 47 Decoding Financial 47 EHSK 47 AXGJ 47 visit www.altairnano.com 47 expressed orimplied 47 www.inter citic.com 47 SearchHelp communications 47 zileuton IV 47 www.novartis.com 47 Tumbleweed cautions 47 Savkino 47 ARE USED THEY IDENTIFY 47 oral talactoferrin 47 Rurban undertakes 47 OmniComm intends 47 www.soliris.net 47 LOOKING INFORMATION 47 generation radiolabeled antibody 47 statements ofhistorical fact 47 MYTHOS trial 47 absorbable gelatin sponge 47 Protox 47 CHDT SEC Filings 47 Caution Concerning Forward Looking 47 suchstatements 47 concerning Ceragon 47 BEMA Buprenorphine 47 MSCRAMM R 47 DPOLT 47 please visit www.advantex.com 47 visit http:/www.parpharm.com 47 Forward lookingstatements 47 Eligard R 47 OLUX R clobetasol propionate 47 SCHERING PLOUGH DISCLOSURE NOTICE 47 markets Testim ® 47 vascular endothelial dysfunction 47 Universal Pandemic Influenza 47 AeroLEF R 47 meaningof Section #A 47 Redishred 47 forward.looking statements 47 www.bioalliancepharma.com 47 Candente relies upon 47 www.positron.com 47 #.These statements 47 Novavax cautions 47 Biojector ® 47 Selective Electrochemical Tumor Ablation 47 BlackRock cautions 47 Feintuch Communications media 47 Protalex 47 biocompatible shelf stable 47 ENTOCORT EC 46 represent BancTec intentions 46 risks anduncertainties 46 www.obagi.com 46 APPY believes 46 Sular formulation 46 NIH registry www.clinicaltrials.gov 46 XTENT 46 Targacept cautions 46 CAUTIONARY STATEMENT Certain 46 ADCC enhanced 46 AuGRID Corporation 46 initiate Phase 2b 46 Alfacell proprietary ribonuclease 46 AnorMED expectation 46 Azimut Qualified Person 46 THIS DOCUMENT CONTAINS CERTAIN 46 statementsare 46 undertakes noobligation 46 Company website www.anormed.com 46 affect Pennichuck Corporation 46 ON FORWARD LOOKING 46 WFWS undertakes 46 Georox Resources Inc. 46 Ontus 46 SmartChip TM 46 looking statements.Forward 46 www.biodeliverysciences.com 46 Note Concerning Forward 46 attributing undue 46 Poly ICR 46 http:/www.marinabio.com 46 KRYSTEXXA ™ 46 http:/www.cytrx.com 46 NGS Collection 46 pre cancerous actinic 46 Innovate Oncology 46 withoutlimitation 46 Cautionary Notice 46 www.mtiglobalinc.com 46 SXLP 46 Urocidin ™ 46 SAFE HARBOR STATEMENT 46 www.genvec.com 46 Safe Harbor Regarding Forward 46 non resectable 46 SKTO 46 companyaEUR TM s 46 website www.octoplus.nl 46 CRHI 46 please visit www.palmharbor.com 46 www.mineralfields.com 46 Elagolix 46 evaluating mipomersen 46 therapeutic anticancer 46 undertake noobligation 46 similarexpressions 46 concerning Pansoft 46 thedate 46 * Potentially libelous 46 please visit http:/www.globalaxcess.biz 46 MEND CABG 46 submit Biologics License 46 undertake anyobligation 46 http:/investors.formfactor.com/edgar.cfm 46 describe UTEK 46 uncertainties thatcould cause 46 CommVault beliefs 46 services visit www.nirvanix.com 46 TNFerade ™ 46 basedon 46 neuro inflammatory disorders 46 CAUTIONARY STATEMENT 46 results performance orachievements 46 Embolic Protection Device 46 www.victorynickel.ca 46 Safe Harbor Disclosure 46 Connetics disclaims 46 TheCompany 46 aEUR aEUR aEUR 46 ClearOne assumes 45 CEO WE SEEK 45 herein Kilroy Realty 45 SHOULD BE READ 45 www.h2oinnovation.com 45 www.patheon.com 45 concerning AudioCodes 45 Kunekt Corporation 45 SearchMedia cautions readers 45 Forwardlooking statements 45 FOLFOX6 chemotherapy regimen 45 Tovaxin TM 45 novel therapeutic modality 45 www.timhortons.com en 45 visit www.jbhunt.com 45 http:/www.clearwire.com 45 Auxilium anticipates 45 update anyforward looking 45 www.pharsight.com 45 Accurately estimating 45 Cautionary Language 45 BCR ABL inhibitors 45 #.Forward looking 45 Panzem ® 45 iii Cubist 45 CryoSeal 45 http:/www.autochinaintl.com 45 exhibits hereto constitute 45 provide TransCanada securityholders 45 events orcircumstances 45 Thomas Skimming P.Eng 45 www.inmetmining.com 45 Announce Collaboration Agreement 45 www.facetbiotech.com 45 Cautionary Disclaimer 45 orimplied 45 limitedto 45 Emailwire.com ™ http:/www.emailwire.com 45 Equant assumes 45 visit http:/www.cytrx.com 45 GenVec assumes 45 www.crowflight.com 45 website www.rxipharma.com 45 Gestiva TM 45 Streetinvesting.com undertakes 45 www.pluristem.com 45 date hereof disclaim 45 AMLH 45 ColorectAlert TM 45 www.psbusinessparks.com 45 http:/www.hqfish.com 45 projections anticipations 45 hyaluronic 45 Agennix undertakes 45 INAMED 45 www.amagpharma.com 45 OctoPlus NV 45 cause actualresults 45 These statementsare 45 PCTEL disclaims any 45 www.enterraenergy.com 45 Cutanea Life Sciences 45 OTCBB NNBP Nanobac 45 fennel herbal teas 45 www.xzeres.com 45 SAFE HARBOR Certain 45 futureperformance 45 Safe harbor provisions 45 estrogen receptor modulator 45 eFlow R 45 CAUTIONARY STATEMENT REGARDING FORWARD 45 proprietary adenovector technology 45 OTI visit www.otiglobal.com 45 respecting DST 45 website http:/www.adolor.com 45 relapsed leukemia 45 PHOLED TM 45 Lux Bioscience 45 visit http:/accelrys.com/ 45 Iomai undertakes 45 BancTec intentions 45 Ateba Resources Inc. 45 BOWMORE 45 CAN GENERALLY BE IDENTIFIED 45 visit http:/www.emcore.com 45 AND OBJECTIVES OR 45 PLACE UNDUE RELIANCE ON 45 MQ Associates 45 regarding Heska 45 www.scminerals.com 45 Aumento 45 NovAtel assumes 45 Albuferon TM 45 visit www.smuckers.com 45 eTelecare assumes 45 www.methylgene.com 44 GELV gasification technology 44 Company proprietary INACTINE 44 Luna Innovations undertakes 44 reflect VIQ Solutions 44 anticancer therapeutics 44 http:/www.allos.com 44 Roland Sartorius 44 www.tri valleycorp.com 44 Caution Regarding Forward Looking 44 Prodrug TAP technology 44 Looking Statements Certain 44 whenever SOAPWIRE 44 Fischer Zoth 44 http:/www.millennium.com/ 44 Pericom assumes 44 http:/www.BearingPoint.com 44 CYDY 44 osteoporotic spines 44 Haldex discloses 44 www.metabolix.com 44 Ausam 44 platforms GVAX 44 cloxacillin 44 LocatePLUS Statements 44 www.synchronica.com 44 DepoBupivacaine TM 44 www.panafrican.com 44 please visit www.cpexpharm.com 44 TeliaSonera AB discloses 44 internet website www.mcmoran.com 44 PINKSHEETS THRA 44 monoclonal antibody biologic 44 Newtek beliefs 44 Antigenics undertakes 44 OraSure Technologies undertakes 44 ReNvision 44 aEUR aEUR 44 Kitsault molybdenum mine 44 initiate Phase IIa 44 theglobe.com inc 44 Balchem expectation 44 TSX VENTURE PPY.A TSX 44 Currently RegeneRx 44 involve anumber 44 www.semafo.com 44 PAIVIS intends 44 Numerex assumes 44 TAXUS Element Stent System 44 Atheros disclaims 44 causeactual results 44 Palatin intends 44 www.itron.com 44 negatives thereof variations thereon 44 PMX # antibiotic 44 Phase 1b trial 44 Pervasip actual 44 Lajitas gold 44 update theseforward looking 44 express Luminex 44 furnished herewith 44 harbor provisions 44 cadmium cobalt 44 Explor Resources inc 44 polymeric formulations 44 MethylGene inherently involve 44 Hejia Software 44 Theravance assumes 44 concerning Intercell AG 44 XplosiveStocks.com undertakes 44 www.catalystpharma.com 44 ViiV Healthcare 44 Ronald L. Parratt 44 maycause 44 Playlogic assumes 44 evaluating carfilzomib 44 Looking Statements Statements 44 Nanobac Pharmaceuticals Inc. 44 Document Capture undertakes 44 Jim DeMesa - 44 Private Securities LitigationReform Act 44 financialperformance 44 Legislation Reform Act 44 manufactures minimally invasive 44 www.smokefree innotec.com 44 GTC undertakes 44 website www.novavax.com 44 WesternOne Equity assumes 44 ImmuneRegen undertakes 44 Addex Pharmaceuticals Ltd 44 unaudited condensed 44 asof 44 Enhanze TM Technology 44 www.igate.com 44 please visit http:/www.gulfresourcesinc.cn 44 minimally dilutive 44 reflect events orcircumstances 44 http:/www.verisign.com/ 44 forward lookingstatements 44 QuikByte 44 Anthracite cautions 44 assumes noobligation 44 www.fossil.com 44 Sciax Corp. 44 tellurium selenium iridium 44 PMX # heptagonist 44 www.approachresources.com 44 APNB believes 44 Peter Mordaunt P.Geo 43 InKine 43 www.geovax.com 43 www.art.ca. 43 iscurrently 43 MPEH ™ 43 please visit http:/www.biogenidec.com 43 rPA vaccine candidate 43 forodesine hydrochloride 43 Announce Merger Agreement 43 FirstCyte 43 regarding allosteric modulators 43 Multiplied Media announces 43 attached condensed consolidated 43 PLACE UNDUE IMPORTANCE ON 43 GDTK 43 Company patented BEMA 43 NeutroTest 43 anticipations estimates 43 encompass SkyWest 43 Risks Regarding Forward 43 embolic protection device 43 proprietary Capillary Aerosolization Technology 43 stated Zackary Irani 43 NexVas TM PR 43 derivations thereof 43 http:/www.cimatron.com 43 factors APPY 43 Reiterates Fiscal 43 AMERICAN PACIFIC CORPORATION Consolidated 43 mysunshinecoast.com.au may 43 http:/www.JazzPharmaceuticals.com 43 QuoteMedia intends 43 Q4 CY# 43 IFTH Acquisition Corp. 43 http:/www.bearingpoint.com/ 43 Announces Licensing Agreement 43 calc silicates 43 treat GI GVHD 43 Wellgreen Mine Property 43 schedules hereto 43 6R BH4 tetrahydrobiopterin naturally 43 Elixir Gaming cautions 43 Kimchee Kronicles 43 please visit www.mscsoftware.com 43 GALNS N acetylgalactosamine 43 see www.virexx.com 43 PRECISE Trial 43 candidate Trofex TM 43 unaudited consolidated balance sheets 43 Pixelplus assumes 43 looking statementswithin 43 www.magnetek.com 43 Nephros filings 43 CYCLOSET ® 43 regarding AngelCiti 43 NO ASSURANCES THAT 43 www.bankofny.com 43 Publication Classified Ad 43 Company undertakes noobligation 43 Cautionary Language Concerning Forward 43 http:/www.amdl.com 43 ATK undertakes 43 www.entropic.com 43 metastatic colorectal carcinoma 43 OR INFORMATION 43 TTGL 43 http:/www.anadyspharma.com 43 Safe Harbor Statement Regarding 43 Synaptics assumes 43 website www.corriente.com 43 Valcon Acquisition BV 43 Vince Sorace President 43 VIOXX Lawsuits 43 http:/www.pdi-inc.com 43 http:/english.homeinns.com 43 eSensor detection technology 43 mention Platinex 43 PreMarketData.com undertakes 43 OrCrude TM process 43 www.nuinsco.ca 43 Resurgex 43 Telesso 43 CESTC 43 thoseexpressed 43 Kittila Mine 43 Aventine disclaims 43 hydrophobic docetaxel prodrug nanoparticle 43 Williesha C. Lakin 43 etquot 43 Corebox.net 43 ImmuneRegen intends 43 Engages Investor Relations 43 Company OTCBB CXDC 43 androgen receptor antagonist 43 AVANIR disclaims any 43 sells Osteocel R 43 Novelis intentions 43 IRBS 43 muscarinic receptor agonists 43 CareView Communications Inc. 43 market fluctuations investee 43 www.elcompanies.com 43 VBLOC vagal blocking 43 concerning Epigenomics AG 43 cerebro cardiovascular disease 43 RELIANCE UPON ANY FORWARD 43 rhITF 43 seeking quali MORE 43 Investigational Device Exemption 43 Lockerby Depth 43 EDGAR www.sec.gov edgar.shtml 43 Girard M.Sc. P.Geo 43 GreenHunter Energy undertakes 43 Sucampo Pharmaceuticals 43 concerning Idera Pharmaceuticals 43 SURFCAM V#.# 43 Cytogen periodic filings 43 rapid thyroid stimulating 43 Biophan anticipates 43 intents beliefs 43 AGCO disclaims 43 concerning Groupe Bikini 43 MicroTel 43 http:/www.bmpsunstone.com 43 ProUroCare undertakes 43 www.bankozarks.com 43 Cellceutix actual 42 Segala gold 42 http:/www.immtechpharma.com 42 Trofile Assay 42 visit www.cytrx.com 42 Kungsleden AB publ discloses 42 AirIQ perception 42 FINANCIAL CONDITION AND 42 website www.magindustries.com 42 www.enerplus.com 42 Minas de Ameca 42 toupdate 42 GTC cautions investors 42 Phase III multicenter 42 CAUTIONARY NOTE REGARDING FORWARD 42 Channeling PMC procedure 42 myFreightWorld vision 42 extruded sheet 42 JM Dutton adds 42 Condensed Consolidated Income 42 Calcium Magnesium 42 Receives Stockholder Approval 42 Viral Genetics believes 42 proprietary Tumor Activated 42 pressrelease 42 indebtedness covenant 42 Convera assumes 42 www.pennichuck.com 42 Novavax assumes 42 www.care view.com 42 condensed consolidated interim 42 Cotavance 42 GroupWeb EmailWire.com 42 http:/www.shire.com 42 U2B R 42 regarding Anviron 42 SHAREHOLDERS CONCERNING FORWARD LOOKING 42 PrivateSecurities Litigation Reform Act 42 obligation toupdate 42 opto electronic transceiver 42 ENRICH trial 42 Amedia assumes 42 http:/www.torreypinestherapeutics.com 42 patented BEMA 42 BUYINS.NET undertakes 42 Qualified Person overseeing Lydian 42 website www.bemis.com 42 Sify undertakes 42 Inc. NASDAQ EVVV 42 SAFE HARBOR Statements 42 Condensed Consolidated Interim 42 www.energytransfer.com 42 Javo ® 42 SupportSoft assumes 42 affecting ChinaNet 42 Insmed disclaims 42 Intravenous palifosfamide 42 www.addaxpetroleum.com 42 futureevents 42 Pilanesberg Project 42 Rexahn assumes 42 www.boehringer ingelheim.com 42 Congoleum undertakes 42 www.macdonaldmines.com 42 narrows Quick Facts 42 Quantech TM 42 BioNeutral routinely 42 Cautionary Note Concerning Forward 42 · Oversee 42 www.chesapeakelodgingtrust.com 42 Helinx technology 42 footnotes thereto 42 table reconciles 42 ATMI undertakes 42 ® pioglitazone HCl 42 www.option.com 42 AusAm 42 website www.emcinsurance.com 42 Looking Statements Except 42 Thalomid R 42 SoftScan ® 42 e# periodic 42 BYSD 42 GroupWeb Emailwire.com 42 http:/www.inhibitex.com 42 variations thereon 42 concerning BioAlliance Pharma 42 differ materiallyfrom 42 Severe hypersensitivity reactions 42 Evidence Therapeutic study 42 http:/www.omtr.com 42 aEUR aEUR aEUR aEUR 42 FEGR disclaims 42 visit www.geokinetics.com 42 Cognex disclaims 42 MIGENIX assumes 42 Infonet undertakes 42 PFIZER DISCLOSURE NOTICE 42 through GroupWeb EmailWire.Com 42 Gahcho Kué 42 www.hcpi.com 42 Macrovision assumes 42 www.medivation.com 42 http:/www.wendys-invest.com/safeharbor 42 DESCRIBED IN THE 42 www.affymax.com 42 Disclosure Booklet containing 42 GrowthWorks refers 42 Ensurge 42 OTCBB TMBXF 42 confirmatory Phase 3 42 EnCana GasCo 42 IN SUCH FORWARD 42 www.infonet.com 42 http:/www.globenewswire.com/newsroom/prs/?pkgid=#Makayama 42 www.firstdata.com 42 antimicrobial biomaterials 42 TSX VENTURE MDV FRANKFURT 42 http:/www.agilysys.com 42 Theragenics TM 42 HyperSolar concentrator 42 www.alliedenergy.com 42 ePlus undertakes 42 generally identifiable 42 develop PS# 42 NII Holdings disclaims 42 Aida Pharmaceuticals 42 CVx ChannelVision Expo 42 Programmable Solutions 42 transdermal therapies 42 Pharsight assumes 42 Icefloe 42 containing active oxychlorine 42 Timminco disclaims any 42 distributed via SourceWire 42 www.ipsen.com 42 ProPhotonix 42 Cetrorelix pamoate 42 highly prospective Deseado 42 Kitsault molybdenum 42 compound CIP FENOFIBRATE 42 TSX PLB leading 42 OSISKO 42 turmeric curcumin 42 www.nano 42 SANnet 42 unaudited condensed consolidated 42 FairPoint undertakes 42 extractive distillation 41 Pieter Wolters President 41 FINANCIAL PROJECTIONS 41 Redback Networks assumes 41 Biojector R 41 www.kmgchemicals.com 41 READER ADVISORY 41 multicenter Phase III 41 SoftScan R 41 BUSINESS OUTLOOK 41 www.orasure.com 41 QTinno TM 41 release contains 41 Croxall Property 41 CPEX undertakes 41 DIIG 41 Jerry Cutini 41 www.covantaholding.com 41 Vaccine Enhancement 41 -Hanzala Malik 41 PPG Industries periodic 41 Tucows assumes 41 visit www.GazooEnergyGroup.com 41 www.enteromedics.com 41 Immunicon cautions investors 41 LOOKING STATEMENTS 41 www.adept.com 41 www.roxmark.com 41 4SC commented 41 Agere Agere Systems 41 uncertaintiesthat 41 accompanying condensed consolidated 41 Sepracor anticipates 41 drugs alitretinoin ceftobiprole 41 looking statements.These 41 estimates pro formas 41 RockResorts Spa 41 SG undertakes 41 Interim Required Filings 41 Ardent Mines 41 Stephen Ghiglieri 41 www.baxa.com 41 3Power 41 Colfax disclaims 41 www.givenimaging.com 41 Completes Recapitalization 41 Agennix AG 41 Cozamin copper 41 PINKSHEETS LYJN 41 UroCool 41 Anaprox 41 please visit www.globalcapacity.com 41 Lyron Bentovim 41 Kip Hallman 41 financialresults 41 Nasdaq GORX 41 ASUR filings 41 consolidated condensed 41 Mucotrol 41 operates Altira Macau 41 anduncertainties 41 www.amerigon.com 41 TRAFINA 41 www.rtgventures.com 41 Beyond naproxcinod NicOx 41 CLIRS trial 41 www.comfortsystemsusa.com 41 Darwin LIMS 41 STATEMENTS AND 41 Regan Chernish P.Geol 41 aEURoeanticipatesaEUR aEURoedraftaEUR aEURoeeventuWainohu 41 Gold Canyon Springpole 41 website www.iamgold.com 41 PRC Yuhe 41 allogeneic epidermal 41 magnesium stearate 41 condensed consolidated balance sheets 41 NASDAQ EPMD 41 Investus 41 Nuinsco believes 41 KCSA Worldwide Website 41 anticipates foresees forecasts 41 statements encompass Sento 41 Questcor intellectual property 41 serious cardiovascular thrombotic 41 wettable powder 41 Phase 1a clinical 41 without limitation EMRISE 41 ANDAs pending 41 #.These forward 41 Sedar.com 41 website www.encana.com 41 visit www.c cor.com 41 Phe restricted diet 41 biopreservation media products 41 stylized Altera logo 41 Snoline 41 #.#M outstanding Pharmaceuticals 41 www.timhortons.com 41 www.bannermanresources.com 41 OTCBB EPDS 41 toreflect 41 forodesine hydrochloride BCX 41 www.wnr.com 41 Safe Harbors created 41 indications contraindications 41 actualresults 41 Enlarged Group 41 Aurizona gold 41 website http:/www.diodes.com 41 Corp UTHR 41 THE CANADIAN SECURITIES AUTHORITIES 41 www.medipattern.com 41 please visit www.cavitationtechnologies.com 41 Peter Dasler P.Geo 41 www.vertexenergy.com 41 website www.diamyd.com 41 Inc. Nasdaq CRDC 41 Miraculins cautions 41 Zonagen 41 provinces Zhejiang Fujian 41 FORWARD LOOKING INFORMATION 41 www.medicaretech.com 41 Synbiotics Corporation 41 website www.anci care.com 41 www.nashfinch.com 41 phenylalanine hydroxylase PAH 41 filingswith 41 forwardlooking statements 41 www.augencc.com 41 OV# CMOS image 41 Muskox kimberlite 41 XSEL undertakes 41 dayrate amounts 41 http:/www.cnoocltd.com 41 Reconciliation Tables 41 companyas 41 GigOptix disclaims any